Standigm

Standigm is a biopharmaceutical company leveraging cutting-edge AI technology to revolutionize drug discovery and development.

Standigm is a biopharmaceutical company that uses artificial intelligence (AI) to streamline and accelerate the process of developing new medications. The company employs advanced AI platforms to identify novel drug targets, design compounds, and optimize lead molecules. Standigm’s technology covers various stages of drug discovery, from target identification to lead generation, with a focus on reducing costs and time compared to traditional methods.

Persist AI

Persist AI is an AI-enabled cloud formulation lab that helps discovery teams build formulations 10 times faster and cheaper.

Persist AI is a pharmaceutical technology company that combines artificial intelligence and robotics to accelerate drug formulation development. They offer a cloud lab service, allowing scientists to design experiments remotely while robots execute them.

Deep Genomics

Deep Genomics is in the field of drug discovery and development using AI to identify novel targets for therapeutic intervention.

Deep Genomics develops RNA-based therapies using artificial intelligence. Their AI platform analyzes genomic data to identify therapeutic targets and design drug candidates for genetic diseases. The company focuses on treating metabolic disorders and neurological conditions. Their proprietary technology, including the AI Workbench and BigRNA foundation model, enables efficient discovery of novel biological mechanisms and potential treatments that traditional methods might miss.

Cyclica

Cyclica is a trailblazer in the field of drug discovery, leveraging the power of artificial intelligence to develop new medicines.

Cyclica (acquired by Recursion) is a biotechnology company that uses artificial intelligence and computational biophysics to revolutionize drug discovery. Their innovative platform combines ligand design for multi-targeted drug creation and ligand express for off-target profiling. This approach allows for the efficient development of novel therapeutics while minimizing unwanted side effects. Cyclica’s technology enables faster, more cost-effective drug discovery processes, focusing on areas such as central nervous system disorders, oncology, and autoimmune diseases.

BenevolentAI

BenevolentAI is a healthcare company revolutionizing the field of drug discovery and development with its innovative use of AI.

BenevolentAI is a technology company that uses artificial intelligence to accelerate drug discovery and development. They combine machine learning with scientific expertise to analyze vast amounts of biomedical data, identify potential drug targets, and predict drug candidates.

Cloud Pharmaceuticals

Cloud Pharmaceuticals is an AI-based drug company, a leader in the field of Artificial Intelligence based drug discovery and development.

Cloud Pharmaceuticals is a biotechnology company that leverages advanced AI and cloud computing technology to accelerate drug discovery and development. They focus on using Generative AI to improve the efficiency of various stages in the pharmaceutical process, including target identification, lead optimization, and clinical trial management.

Atomwise

Atomwise is a preclinical pharma company revolutionizing how drugs are discovered using an Artificial intelligence (AI) engine.

Atomwise is a technology-enabled pharmaceutical company that uses artificial intelligence and deep learning to discover and develop small-molecule drugs. Its AI discovery engine applies structure-based drug design to identify and optimize novel chemical compounds against biological targets. Atomwise uses its technology for molecular discovery and maintains a proprietary pipeline of small-molecule drug candidates, combining computational AI methods with pharmaceutical research and development.